Coppola D - Search Results

1

Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.

Balasis ME, Forinash KD, Chen YA, Fulp WJ, Coppola D, Hamilton AD, Cheng JQ, Sebti SM. Balasis ME, et al. Among authors: coppola d. Clin Cancer Res. 2011 May 1;17(9):2852-62. doi: 10.1158/1078-0432.CCR-10-2544. Clin Cancer Res. 2011. PMID: 21536547 Free PMC article.

2

Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.

Irby R, Mao W, Coppola D, Jove R, Gamero A, Cuthbertson D, Fujita DJ, Yeatman TJ. Irby R, et al. Among authors: coppola d. Cell Growth Differ. 1997 Dec;8(12):1287-95. Cell Growth Differ. 1997. PMID: 9419417

3

The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.

Coppola D, Saunders B, Fu L, Mao W, Nicosia SV. Coppola D, et al. Cancer Res. 1999 Jul 1;59(13):3264-70. Cancer Res. 1999. PMID: 10397275

4

Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, Jove R, Yu H. Niu G, et al. Among authors: coppola d. Cancer Res. 1999 Oct 15;59(20):5059-63. Cancer Res. 1999. PMID: 10537273

5

The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis.

Jiang K, Coppola D, Crespo NC, Nicosia SV, Hamilton AD, Sebti SM, Cheng JQ. Jiang K, et al. Among authors: coppola d. Mol Cell Biol. 2000 Jan;20(1):139-48. doi: 10.1128/MCB.20.1.139-148.2000. Mol Cell Biol. 2000. PMID: 10594016 Free PMC article.

6

Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.

Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, Jiang C, Coppola D, Nicosia SV, Cheng JQ. Yuan ZQ, et al. Among authors: coppola d. Oncogene. 2000 May 4;19(19):2324-30. doi: 10.1038/sj.onc.1203598. Oncogene. 2000. PMID: 10822383

7

Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice.

Blaskovich MA, Lin Q, Delarue FL, Sun J, Park HS, Coppola D, Hamilton AD, Sebti SM. Blaskovich MA, et al. Among authors: coppola d. Nat Biotechnol. 2000 Oct;18(10):1065-70. doi: 10.1038/80257. Nat Biotechnol. 2000. PMID: 11017044

8

Retinoblastoma protein activation of interleukin 8 expression inhibits tumor cell survival in nude mice.

Zhang H, Wei S, Sun J, Coppola D, Zhong B, Wu GD, Goodwin B, Sebti S, Djeu JY, Blanck G. Zhang H, et al. Among authors: coppola d. Cell Growth Differ. 2000 Dec;11(12):635-9. Cell Growth Differ. 2000. PMID: 11149598

9

CEP1612, a dipeptidyl proteasome inhibitor, induces p21WAF1 and p27KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice.

Sun J, Nam S, Lee CS, Li B, Coppola D, Hamilton AD, Dou QP, Sebti SM. Sun J, et al. Among authors: coppola d. Cancer Res. 2001 Feb 15;61(4):1280-4. Cancer Res. 2001. PMID: 11245420

10

Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.

Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ. Sun M, et al. Among authors: coppola d. Cancer Res. 2001 Aug 15;61(16):5985-91. Cancer Res. 2001. PMID: 11507039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters